Your session is about to expire
← Back to Search
Behavioural Intervention
Memory Supports for Cognitive Impairment
N/A
Recruiting
Led By Michael Scullin, PhD
Research Sponsored by Baylor University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
At the current time, individuals who do not identify as conversational in English will be excluded from participation.
Uncorrected hearing loss, vision loss, or motor dysfunction significant enough to interfere with training.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test the effectiveness of using smartphone reminder apps to improve memory in individuals with mild cognitive impairment or mild dementia. The study will involve 200 participants, half of whom are from digitally-dis
Who is the study for?
This trial is for individuals with Alzheimer's Disease, Cognitive Impairment, or Mild Dementia. It aims to include people from digitally-disadvantaged backgrounds as well. Participants should be able to complete memory assessments and willing to use either a smartphone app or paper-based system.
What is being tested?
The study compares the effectiveness of a smartphone reminder app against a paper-based memory support system in improving prospective memory (remembering future tasks). The trial will involve baseline assessments, a 4-week intervention period with booster sessions, and follow-ups at 3 and 6 months.
What are the potential side effects?
There may not be direct side effects from using digital or paper-based memory aids; however, participants might experience frustration or stress if they find the technology challenging or if it doesn't aid their memory as expected.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am conversational in English.
Select...
I do not have severe hearing, vision, or motor issues that would stop me from participating in training.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured during screening and at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured during screening and at 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Caregiving-Related Quality of Life
Objective Prospective Memory Performance
Patient-Centered/Patient-Selected Prospective Memory Performance
Secondary study objectives
Calendar Use
Caregiving Cognitive Burden
Coping Self-Efficacy
+16 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Smartphone-based appExperimental Treatment1 Intervention
Participants will use Google Calendar, an off-the-shelf app that is free and user-friendly, to provide reminders on their smartphone to perform prospective memory tasks at the appropriate time. In the current study, participants will offload their personal and experimentally assigned tasks into the digital calendar with reminders enabled.
Group II: Paper-based notebookActive Control1 Intervention
Participants will use a Memory Support System, which is an established paper-based calendar and note taking system that can fit into one's pocket. In the current study they will use the system to offload personal and experimentally assigned tasks and notes into the schedule, to-do list, and journal sections of the notebook.
Find a Location
Who is running the clinical trial?
University of Texas at AustinOTHER
378 Previous Clinical Trials
86,409 Total Patients Enrolled
Baylor UniversityLead Sponsor
62 Previous Clinical Trials
65,860 Total Patients Enrolled
Baylor Scott and White HealthOTHER
17 Previous Clinical Trials
61,140 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,805 Previous Clinical Trials
28,194,657 Total Patients Enrolled
Michael Scullin, PhDPrincipal InvestigatorBaylor University
1 Previous Clinical Trials
52 Total Patients Enrolled